Engineering of novel Staphylococcal Protein A ligands to enable milder elution pH and high dynamic binding capacity.

We describe novel Staphylococcal Protein A ligands that enable milder elution pH for use in affinity chromatography. The change in elution pH is the result of point mutations to the protein sequence. Two novel ligands are investigated in this study. The first, designated Z(H18S)4, represents a histidine to serine substitution single mutation. The second, designated Z(H18S, N28A)4, is a double mutant comprising histidine to serine and asparagine to alanine mutations. Both are compared against the unmutated sequence, designated Z4, which is currently utilized in a commercially available Protein A stationary phase for the purification of molecules containing Fc domains. The ligands are coupled to a chromatography support matrix and tested against a panel of antibodies and an Fc fusion protein for elution pH, dynamic binding capacity, step-wise elution, and capture from clarified culture media. Results demonstrate that the novel ligands result in milder elution pH, on average >0.5 pH units, when tested in a pH gradient. For step-wise elution at pH 4.0, the Z(H18S, N28A)4 ligand showed on average a greater than 30% increase in yield compared to Z4. Importantly, for the antibodies tested the mutations did not result in a decrease in dynamic binding capacity or other desirable attributes such as selectivity. A potential application of the novel ligands is shown with a pH sensitive molecule prone to aggregation under acidic conditions.

[1]  Brian D. Kelley,et al.  Purification Strategies to Process 5 g/L Titers of Monoclonal Antibodies : Altering the order of operations, using new resins, and increasing dynamic binding capacity can obviate the need for major facilty changes , 2009 .

[2]  Sanchayita Ghose,et al.  Antibody variable region interactions with Protein A: implications for the development of generic purification processes. , 2005, Biotechnology and bioengineering.

[3]  M. Uhlén,et al.  Protein engineering of an IgG-binding domain allows milder elution conditions during affinity chromatography. , 2000, Journal of biotechnology.

[4]  Alois Jungbauer,et al.  Comparison of protein A affinity sorbents II. Mass transfer properties. , 2005, Journal of chromatography. A.

[5]  P. Gagnon Technology trends in antibody purification. , 2012, Journal of chromatography. A.

[6]  S. Hober,et al.  Protein A chromatography for antibody purification. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[7]  M. Taussig,et al.  Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: structural basis for recognition of B-cell receptors and superantigen activity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[8]  María Vázquez-Rey,et al.  Aggregates in monoclonal antibody manufacturing processes , 2011, Biotechnology and bioengineering.

[9]  D. Ejima,et al.  Elution of antibodies from a Protein-A column by aqueous arginine solutions. , 2004, Protein expression and purification.

[10]  D. Missiakas,et al.  Recurrent infections and immune evasion strategies of Staphylococcus aureus. , 2012, Current opinion in microbiology.

[11]  Janice M Reichert,et al.  mAb therapeutic products and risk management , 2010, mAbs.

[12]  P. Hinckley,et al.  Host cell protein clearance during protein a chromatography: Development of an improved column wash step , 2008, Biotechnology progress.

[13]  A. Surolia,et al.  Protein A: nature's universal anti-antibody , 1982 .

[14]  G. Silverman B cell superantigens: possible roles in immunodeficiency and autoimmunity. , 1998, Seminars in immunology.

[15]  Sanchayita Ghose,et al.  Binding capacity differences for antibodies and Fc‐fusion proteins on protein A chromatographic materials , 2007, Biotechnology and bioengineering.

[16]  B. Nogal,et al.  Select host cell proteins coelute with monoclonal antibodies in protein a chromatography , 2012, Biotechnology progress.

[17]  R. Kelley,et al.  Antibody variable region binding by Staphylococcal protein A: Thermodynamic analysis and location of the Fv binding site on E‐domain , 1999, Protein science : a publication of the Protein Society.

[18]  I. Shimada,et al.  NMR study of the interaction between the B domain of staphylococcal protein A and the Fc portion of immunoglobulin G. , 1998, Biochemistry.

[19]  J. Deisenhofer Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. , 1981, Biochemistry.

[20]  G T Montelione,et al.  High-resolution solution NMR structure of the Z domain of staphylococcal protein A. , 1997, Journal of molecular biology.

[21]  R. Bayer,et al.  Recovery and purification process development for monoclonal antibody production , 2010, mAbs.

[22]  Brian Kelley,et al.  Industrialization of mAb production technology: The bioprocessing industry at a crossroads , 2009, mAbs.

[23]  Xuejun Han,et al.  Protein aggregation kinetics during Protein A chromatography. Case study for an Fc fusion protein. , 2007, Journal of chromatography. A.

[24]  Sanchayita Ghose,et al.  Protein A Affinity Chromatography for Capture and Purification of Monoclonal Antibodies and Fc-Fusion Proteins: Practical Considerations for Process Development , 2006 .

[25]  Uwe Gottschalk,et al.  Bioseparation in Antibody Manufacturing: The Good, The Bad and The Ugly , 2008, Biotechnology progress.

[26]  Alois Jungbauer,et al.  Comparison of protein A affinity sorbents. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[27]  F. Steindl,et al.  Comparison of protein A affinity sorbents III. Life time study. , 2006, Journal of chromatography. A.

[28]  Brian Kelley,et al.  Very Large Scale Monoclonal Antibody Purification: The Case for Conventional Unit Operations , 2007, Biotechnology progress.

[29]  M. Uhlén,et al.  A synthetic IgG-binding domain based on staphylococcal protein A. , 1987, Protein engineering.

[30]  S. Bottomley,et al.  A study of the interactions between an IgG-binding domain based on the B domain of staphylococcal protein a and rabbit IgG , 1998, Molecular biotechnology.